Apoptosis associated with esophageal adenocarcinoma: Influence of photodynamic therapy

Cancer Letters

Volumn 163, Issue 1, 2001, Pages 33-41

  McGarrity, Thomas J ^a,d   Peiffer, Laurie P ^a   Granville, David J ^b,c   Carthy, Christopher M ^b,c   Levy, Julia G ^b,c   Khandelwal, Mukul ^a   Hunt, David W C ^b  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b QLT PhotoTherapeutics Inc   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

Apoptosis; Caspase 3; Photodynamic therapy

Indexed keywords

CASPASE 3; PHOTOFRIN; PROTEIN BCL 2; PROTEIN P53;

ADULT; AGED; APOPTOSIS; ARTICLE; CELL DEATH; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; ENZYME ACTIVITY; ESOPHAGUS CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; IN VITRO STUDY; MALE; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; TREATMENT OUTCOME;

ADENOCARCINOMA; AGED; APOPTOSIS; BLOTTING, WESTERN; CASPASE 3; CASPASES; ENZYME PRECURSORS; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PHOTOCHEMOTHERAPY; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0035835488     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(00)00663-7     Document Type: Article

References (39)

1. Photodynamic therapy in oncology: Mechanisms and clinical use
2. Photodynamic therapy with porfimer sodium versus thermal ablation therapy with Nd:YAG laser for palliation of esophageal cancer: A multicenter randomized trial
3. Photodynamic therapy for early stage bronchogenic carcinoma
4. Photophysical and photobiological processes in the photodynamic therapy of tumours
5. Lysosomes, a key target of hydrophobic photosensitizers proposed for photochemotherapeutic applications
6. Singlet oxygen intermediacy in the photodynamic action of membrane-bound hematoporphyrin derivative
7. Oxygen consumption and diffusion effects in photodynamic therapy
8. Photodynamic therapy induces rapid cell death by apoptosis in L5278Y mouse lymphoma cells
9. Apoptosis during photodynamic therapy-induced ablation of RIF-1 tumors in C3H mice: Electron microscopic, histopathologic and biochemical evidence
10. Phospholipase activation triggers apoptosis in photosensitized mouse lymphoma cells
11. Apoptosis during photodynamic therapy-induced ablative RIF-1 tumors in C3H mice
12. Photodynamic therapy with Photofrin II induces programmed cell death in carcinoma cell lines
13. Rapid initiation of apoptosis by photodynamic therapy
14. The induction of partial resistance to photodynamic therapy by the proto-oncogene BCL-2
15. Apoptosis: A basic biological phenomenon with wide ranging implications in tissue kinetics
16. To die or not to die. An overview of apoptosis and its role in disease
17. Cell death by apoptosis: Basic concepts and disease relevance for the gastroenterologist
18. Apoptosis is inhibited early in the dysplasia-carcinoma sequence of Barrett esophagus
19. Protease activation during apoptosis: Death by a thousand cuts?
20. Human ICE/CED-3 protease nomenclature
21. Rapid cytochrome c release, activation of caspases 3, 6, 7 and 8 followed by Bap31 cleavage in HeLa cells treated with photodynamic therapy
22. Apopain/CPP32 cleaves proteins that are essential for cellular repair: A fundamental principle of apoptotic death
23. CPP32/Apopain is a key interleukin 1β converting enzyme-like protease involved in Fas-mediated apoptosis
24. Photodynamic therapy induces caspase-3 activation in HL-60 cells
25. Clinical implications of the p53 tumor suppressor gene
26. p53 gene point mutations in relation to p53 nuclear protein accumulation in colorectal cancers
27. Bcl-2 and the regulation of programmed cell death
28. Bcl-2 overexpression blocks caspase activation and downstream apoptotic events instigated by photodynamic therapy
29. p53 in tumour pathology: Can we trust immunohistochemistry? - Revisited!
30. bcl-2 and p53 oncoprotein expression during colorectal carcinogenesis
31. L prevents caspase-3-mediated activation of DNA fragmentation factor (DFF) produced by treatment with the photochemotherapeutic agent BPD-MA
32. Inhibition of apoptosis during development of colorectal cancer
33. Inhibition of apoptosis in colon tumors induced in the rat by 2-amino-3-methylimidazo[4,5-f]quinoline
34. Antineoplastic drugs Sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis
35. Histopathologic evaluation of apoptosis in cancer
36. The Fas counterattack in vivo: Apoptotic depletion of tumor-infiltrating lymphocytes associated with Fas ligand expression by human esophageal carcinoma
37. Ionophore-induced apoptosis: Role of DNA fragmentation and calcium fluxes
38. Accumulation of p53 protein in normal, dysplastic, and neoplastic Barrett's oesophagus
39. p53 immunoreactivity in Barrett's metaplasia, dysplasia and carcinoma